stars 1 stars 2 stars 3

ALK-Abelló, headquartered in Hørsholm, Denmark, is a research-driven pharmaceutical company specializing in allergy prevention, diagnosis, and treatment.

Website http://www.alk.net
Ticker AKABY
Revenue $749.8 million
Employees View employees
Founded 1923
Address 6-8 Bøge Allé, Hoersholm DK-2970, DK
Phone +1 512-251-0037
Fax (454) 574-8690
Technologies
Industry Pharmaceuticals, Health Diagnostics, Healthcare, Health Care, Medical, Pharmaceutical
Web Rank 5 Million
Keywords Alk Abello Pipeline, Incentivize Board Of Directors, Alk-Abello B
Competitors Merck & Co., Inc., Sanofi, GSK, アステラス製薬(株), Actavis plc (now Allergan), Novartis, Boehringer Ingelheim, Pfizer, Roche, AbbVie +37 more (view full list)
SIC SIC Code 28 Companies, SIC Code 80 Companies, SIC Code 283 Companies
NAICS NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 541711 Companies, NAICS Code 44 Companies

ALK-Abello Ltd. Questions

The ALK-Abello Ltd. annual revenue was $749.8 million in 2026.

The NAICS codes for ALK-Abello Ltd. are [54, 54171, 5417, 541, 541711, 44].

The SIC codes for ALK-Abello Ltd. are [28, 80, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users